Net profit of Glaxosmithkline Pharmaceuticals declined 63.44% to Rs 26.42 crore in the quarter ended June 2017 as against Rs 72.27 crore during the previous quarter ended June 2016. Sales declined 14.36% to Rs 586.79 crore in the quarter ended June 2017 as against Rs 685.21 crore during the previous quarter ended June 2016.

Powered by Capital Market - Live News

Glaxosmithkline Pharma will hold a meeting of the Board of Directors of the Company on 25 July 2017.

Powered by Capital Market - Live News

Net profit of Glaxosmithkline Pharma rose 6.29% to Rs 112.71 crore in the quarter ended March 2017 as against Rs 106.04 crore during the previous quarter ended March 2016. Sales rose 10.93% to Rs 763.43 crore in the quarter ended March 2017 as against Rs 688.18 crore during the previous quarter ended March 2016.

For the full year,net profit declined 10.08% to Rs 336.78 crore in the year ended March 2017 as against Rs 374.53 crore during the previous year ended March 2016. Sales rose 6.09% to Rs 2920.79 crore in the year ended March 2017 as against Rs 2753.02 crore during the previous year ended March 2016.

Powered by Capital Market - Live News

GlaxoSmithKline Pharma announced that dividend, if approved by the shareholders will be paid after 25 July 2017.

Powered by Capital Market - Live News